IRIS

DE LAURENTIIS, MICHELINO

DE LAURENTIIS, MICHELINO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 307 (tempo di esecuzione: 0.049 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part 1.5 Abstract in rivista 2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 1.1 Articolo in rivista 2011 Davies, C; Godwin, J; Gray, R; Clarke, M; Cutter, D; Darby, S; Mcgale, P; Pan, Hc; Taylor, C; Wang, Yc; Dowsett, M; Ingle, J; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. 1.1 Articolo in rivista 2005 Howell, A; Cuzick, J; Baum, M; Buzdar, A; Dowsett, M; Forbes, Jf; Hoctin Boes, G; Houghton, J; Locker, Gy; Tobias, Js; ATAC Trialists', Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer. 1.1 Articolo in rivista 2014 Criscitiello, C; Disalvatore, D; DE LAURENTIIS, Michelino; Gelao, L; Fumagalli, L; Locatelli, M; Bagnardi, V; Rotmensz, N; Esposito, A; Minchella, I; DE PLACIDO, Sabino; Santangelo, Michele; Viale, G; Goldhirsch, A; Curigliano, G.
Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. 1.1 Articolo in rivista 2011 Harbeck, N; Ewer, Ms; DE LAURENTIIS, Michelino; Suter, Tm; Ewer, Sm
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. 1.1 Articolo in rivista 2011 Giuliano, Mario; Giordano, A; Jackson, S; Hess, Kr; De Giorgi, U; Mego, M; Handy, Bc; Ueno, Nt; Alvarez, Rh; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Valero, V; Hortobagyi, Gn; Reuben, Jm; Cristofanilli, M.
Prognostic factors: rationale and methods of analysis and integration. 1.1 Articolo in rivista 1994 G. M., Clark; S. G., Hilsenbeck; P. M., Ravdin; DE LAURENTIIS, Michelino; C. K., Osborne
External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life. 2.1 Contributo in volume (Capitolo o Saggio) 2003 DI LORENZO, G; Autorino, R; Ciardiello, F; Raben, D; Bianco, C; Troiani, T; Pizza, C; DE LAURENTIIS, Michelino; Pensabene, M; D., ARMIENTO M; Bianco, Ar; DE PLACIDO, Sabino
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. 1.1 Articolo in rivista 1997 Fontanini, G.; Lucchi, M.; Vignati, S.; Mussi, A.; Ciardiello, F.; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Survival, quality of life and breast cancer. 1.1 Articolo in rivista 2001 Mosconi, P; Colozza, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Maltoni, M.
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 1.1 Articolo in rivista 2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
Survival analysis of censored data: neural network analysis detection of complex interactions between variables. 1.1 Articolo in rivista 1994 DE LAURENTIIS, Michelino; P. M., Ravdin
A technique for using neural network analysis to perform survival analysis of censored data. 1.1 Articolo in rivista 1994 DE LAURENTIIS, Michelino; P. M., Ravdin
Targeted Therapy of Breast Cancer 8.01 Chairman di Sessioni di Convegni Internazionali 2009 DE LAURENTIIS, Michelino; Zielinski, C.
Manuale di Oncologia Clinica 2.1 Contributo in volume (Capitolo o Saggio) 1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies 1.5 Abstract in rivista 2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases. 1.1 Articolo in rivista 1996 Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino
Survival Analysis by means of a novel Neural Network Model 1.1 Articolo in rivista 2003 Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination. 1.1 Articolo in rivista 1995 P., Tagliaferri; Matano, Elide; A., Rea; M., Famiani; F., Ciardiello; G., Tortora; V., Montesarchio; A., Morabito; M., Caraglia; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Palmieri, Giovannella; A. R., Bianco
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER. 1.1 Articolo in rivista 2002 DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F.